Article info
PDFCystic fibrosis
Original article
Pseudomonas aeruginosa eradication therapy and risk of acquiring Aspergillus in young children with cystic fibrosis
- Correspondence to Dr Stefanie Hennig, School of Pharmacy, The University of Queensland, Brisbane, QLD 4072, Australia; s.hennig{at}uq.edu.au
Citation
Pseudomonas aeruginosa eradication therapy and risk of acquiring Aspergillus in young children with cystic fibrosis
Publication history
- Received January 17, 2018
- Revised March 31, 2019
- Accepted May 8, 2019
- First published June 15, 2019.
Online issue publication
September 01, 2022
Article Versions
- Previous version (23 July 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.